{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T20:11:54Z","timestamp":1782504714571,"version":"3.54.5"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1097\/ico.0b013e3181c33034","type":"journal-article","created":{"date-parts":[[2010,5,11]],"date-time":"2010-05-11T06:40:44Z","timestamp":1273560044000},"page":"638-640","source":"Crossref","is-referenced-by-count":47,"title":["Topical Treatment With 1% Cyclosporine for Subepithelial Infiltrates Secondary to Adenoviral Keratoconjunctivitis"],"prefix":"10.1097","volume":"29","author":[{"given":"Eliya","family":"Levinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alana","family":"Slomovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiwan","family":"Sansanayudh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irit","family":"Bahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan R","family":"Slomovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210204","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0161-6420(02)00992-2","article-title":"The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study.","volume":"109","author":"Hillenkamp","year":"2002","journal-title":"Ophthalmology"},{"key":"R2-9-20210204","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1001\/archopht.116.7.900","article-title":"The effects of topical nonsteroidal anti-inflammatory drugs on adenoviral replication.","volume":"116","author":"Gordon","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"R3-9-20210204","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/archopht.119.10.1487","article-title":"Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study.","volume":"119","author":"Hillenkamp","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"R4-9-20210204","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1001\/archopht.1978.03910060465016","article-title":"Corneal histology after epidemic keratoconjunctivitis.","volume":"96","author":"Lund","year":"1978","journal-title":"Arch Ophthalmol"},{"key":"R5-9-20210204","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/ICO.0b013e318033bd25","article-title":"Topical cyclosporine a in the treatment of superior limbic keratoconjunctivitis: a long-term follow-up.","volume":"27","author":"Sahin","year":"2008","journal-title":"Cornea"},{"key":"R6-9-20210204","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/ICO.0b013e31812dfab3","article-title":"Management of severe allergic conjunctivitis with topical cyclosporin a 0.05% eyedrops.","volume":"26","author":"Ozcan","year":"2007","journal-title":"Cornea"},{"key":"R7-9-20210204","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0181-5512(07)91357-1","article-title":"[Efficacy of topical 2% cyclosporine A as a steroid-sparing agent in steroid-dependent vernal keratoconjunctivitis].","volume":"30","author":"Doan","year":"2007","journal-title":"J Fr Ophtalmol"},{"key":"R8-9-20210204","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1681\/ASN.V991751","article-title":"Cyclosporin A in patients receiving renal allografts from cadaver donors.","volume":"9","author":"Calne","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"R9-9-20210204","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0039-6257(86)90035-4","article-title":"Cyclosporine: immunology, pharmacology and therapeutic uses.","volume":"31","author":"Nussenblatt","year":"1986","journal-title":"Surv Ophthalmol"},{"key":"R10-9-20210204","first-page":"e7","article-title":"[A case report of a recurrence of Moorens ulcer after cataract surgery].","volume":"30","author":"Schweitzer","year":"2007","journal-title":"J Fr Ophtalmol"},{"key":"R11-9-20210204","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1399-3038.2006.00427.x","article-title":"Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood.","volume":"17","author":"Spadavecchia","year":"2006","journal-title":"Pediatr Allergy Immunol"},{"key":"R12-9-20210204","first-page":"1358","article-title":"Cyclosporine A for the treatment of necrotizing scleritis and corneal melting in patients with rheumatoid arthritis.","volume":"19","author":"McCarthy","year":"1992","journal-title":"J Rheumatol"},{"key":"R13-9-20210204","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/08820530500232035","article-title":"Intermediate uveitis.","volume":"20","author":"Bonfioli","year":"2005","journal-title":"Semin Ophthalmol"},{"key":"R14-9-20210204","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s004170050204","article-title":"Topical cyclosporin A in Thygesons superficial punctate keratitis.","volume":"237","author":"Reinhard","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R15-9-20210204","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.optm.2006.12.014","article-title":"Diagnosis and management of Thygesons superficial punctate keratitis.","volume":"78","author":"Duszak","year":"2007","journal-title":"Optometry"},{"key":"R17-9-20210204","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/01.ico.0000127481.23714.b6","article-title":"Topical cyclosporine A inhibits subepithelial immune infiltrates but also promotes viral shedding in experimental adenovirus models.","volume":"24","author":"Romanowski","year":"2005","journal-title":"Cornea"},{"key":"R18-9-20210204","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3129\/i06-061","article-title":"Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis.","volume":"41","author":"Kilic","year":"2006","journal-title":"Can J Ophthalmol"},{"key":"R19-9-20210204","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s003470070025","article-title":"[Local cyclosporin A in nummuli after keratoconjunctivitis epidemica. A pilot study].","volume":"97","author":"Reinhard","year":"2000","journal-title":"Ophthalmologe"},{"key":"R20-9-20210204","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1600-0420.2007.01046.x","article-title":"Prolonged exposure to topical cyclosporine A does not seem to promote conjunctival malignancy.","volume":"86","author":"Bohringer","year":"2008","journal-title":"Acta Ophthalmol"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0b013e3181c33034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T14:12:53Z","timestamp":1635343973000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-201006000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e3181c33034","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}